Repligen (RGEN) Net Cash Flow Growth (1y) (2011 - 2026)
Repligen (RGEN) Net Cash Flow Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | -342.50% |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | 131.47% |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | -47.85% |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | -40.20% |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | -194.15% |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | - |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | 102.38% |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | 84.02% |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | 144.81% |
| 10 | Repligen | 7.41 Bn | 6.42 Bn | 108.28 Mn | 129.26% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 129.26% |
| Dec 31, 2025 | -657.53% |
| Sep 30, 2025 | 253.30% |
| Jun 30, 2025 | -63.34% |
| Mar 31, 2025 | -334.30% |
| Dec 31, 2024 | -118.96% |
| Sep 30, 2024 | -188.07% |
| Jun 30, 2024 | -67.93% |
| Mar 31, 2024 | 449.04% |
| Dec 31, 2023 | 313.21% |
| Sep 30, 2023 | 299.54% |
| Jun 30, 2023 | 425.78% |
| Mar 31, 2023 | 54.20% |
| Dec 31, 2022 | -380.48% |
| Sep 30, 2022 | 86.52% |
| Jun 30, 2022 | -17.25% |
| Mar 31, 2022 | -2,317.88% |
| Dec 31, 2021 | -107.99% |
| Sep 30, 2021 | -959.38% |
| Jun 30, 2021 | 29.42% |